Molecular Profiling of Infiltrating Urothelial Carcinoma of Bladder and Nonbladder Origin
Open Access
- 1 February 2015
- journal article
- Published by Elsevier in Clinical Genitourinary Cancer
- Vol. 13 (1) , e37-e49
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapyLaboratory Investigation, 2014
- Actionable mutations in muscle-invasive bladder cancerCurrent Opinion in Urology, 2013
- Molecular targets on the horizon for kidney and urothelial cancerNature Reviews Clinical Oncology, 2013
- Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinomaCell Cycle, 2013
- Advanced Urothelial Carcinoma: Overcoming Treatment Resistance through Novel Treatment ApproachesFrontiers in Pharmacology, 2013
- A Meta-Analysis of the Relationship between FGFR3 and TP53 Mutations in Bladder CancerPLOS ONE, 2012
- A Molecular Taxonomy for Urothelial CarcinomaClinical Cancer Research, 2012
- A Systematic Study of Gene Mutations in Urothelial Carcinoma; Inactivating Mutations in TSC2 and PIK3R1PLOS ONE, 2011
- FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and TherapyPLOS ONE, 2010
- HER‐2 and TOP2A coamplification in urinary bladder cancerInternational Journal of Cancer, 2003